Company record
Acella Pharmaceuticals, LLC
0 FDA warning letters since 2023 and 1 recall in the last 12 months.
Get an email the day FDA posts anything new about Acella Pharmaceuticals, LLC.
Recalls
| Reported | Class | Firm | Product and reason |
|---|---|---|---|
| May 13 | Class II | Acella Pharmaceuticals, LLC Drug |
NAPROXEN ORAL SUSPENSION, USP, 125 mg/5mL, Rx only, 16fl oz (473 mL) bottles, Distributed by: Acella Pharmaceuticals, LLC, Alpharetta, GA 30005, Made in Canada NDC 42192-619-16 Chemical contamination; presence of lead and lithium above specification |